Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease
NCT ID: NCT02433990
Last Updated: 2019-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
178 participants
OBSERVATIONAL
2014-04-30
2019-08-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adult Congenital Heart Disease Surgery
NCT00446160
Study on the Transfusional Management of the Patients With Congenital Heart Disease Carried Out in Adulthood.
NCT03063801
The Role of Myocardial Fibrosis in Patients With Aortic Stenosis
NCT01755936
Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve
NCT01700439
Structural Heart and Valve Network PROSPECTIVE Registry
NCT03928639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult Congenital Heart Disease
18 years and older with congenital heart disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate or Complex Congenital Heart Disease
* Willingness to Consent
Exclusion Criteria
* Surgery within 6 months
* Unrepaired cyanotic heart disease
* Patients with Eisenmenger Syndrome physiology
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susan Fernandes
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Fernandes, PA-C, LP.D.
Role: PRINCIPAL_INVESTIGATOR
Stanford Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford Hospital and Clinics
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-28847
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.